Intra Cellular Therapies shares owned by Emerald Advisers
Quarter-by-quarter ownership of Intra Cellular Therapies (ITCI) shares owned by Emerald Advisers
from 13F filings
Historical chart of Emerald Advisers investment in Intra Cellular Therapies
Tip: Access up to 7 years of quarterly data
All positions including Intra Cellular Therapies held by Emerald Advisers consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Intra Cellular Therapies by Emerald Advisers
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $32M | 441k | 73.17 |
| 2024-06-30 | $27M | 393k | 68.49 |
| 2024-03-31 | $28M | 402k | 69.20 |
| 2023-12-31 | $25M | 344k | 71.62 |
| 2023-09-30 | $20M | 382k | 52.09 |
| 2023-06-30 | $21M | 335k | 63.32 |